(15088446), S. Y., (15352614), S. S., (15352611), D. S., (15033960), T. N., (22547757), A. O., (15352623), M. Y., . . . (15352635), A. H. (2025). Supplementary Figure 4 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models.
Citação do estilo Chicago (17ª ed.)(15088446), Shigehiro Yagishita, et al. Supplementary Figure 4 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models. 2025.
Citação MLA (9ª ed.)(15088446), Shigehiro Yagishita, et al. Supplementary Figure 4 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models. 2025.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.